|
Arnsten, Amy F T; Girgis, Ragy R; Gray, David L et al. (2017) Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biol Psychiatry 81:67-77
|
|
Lee, Sang-Min; Yang, Yang; Mailman, Richard B (2014) Dopamine D1 receptor signaling: does G?Q-phospholipase C actually play a role? J Pharmacol Exp Ther 351:9-17
|
|
Lee, Sang-Min; Kant, Andrew; Blake, Daniel et al. (2014) SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C. Neuropharmacology 86:145-54
|
|
Boyd, Kevin N; Mailman, Richard B (2012) Dopamine receptor signaling and current and future antipsychotic drugs. Handb Exp Pharmacol :53-86
|
|
Fowler, J Corey; Bhattacharya, Supriyo; Urban, Jonathan D et al. (2012) Receptor conformations involved in dopamine D(2L) receptor functional selectivity induced by selected transmembrane-5 serine mutations. Mol Pharmacol 81:820-31
|
|
Mailman, Richard B; Murthy, Vishakantha (2010) Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery. Neuropsychopharmacology 35:345-6
|
|
Mailman, Richard B; Murthy, Vishakantha (2010) Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des 16:488-501
|
|
Brown, Justin T; Kant, Andrew; Mailman, Richard B (2009) Rapid, semi-automated, and inexpensive radioimmunoassay of cAMP: application in GPCR-mediated adenylate cyclase assays. J Neurosci Methods 177:261-6
|
|
Ryman-Rasmussen, Jessica P; Griffith, Adam; Oloff, Scott et al. (2007) Functional selectivity of dopamine D1 receptor agonists in regulating the fate of internalized receptors. Neuropharmacology 52:562-75
|
|
Urban, Jonathan D; Vargas, Gabriel A; von Zastrow, Mark et al. (2007) Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67-77
|
Showing the most recent 10 out of 80 publications
